News | March 28, 2024
Caplin Group commences operations of Rs. 150 crore oncology facility
The facility will manufacture tablets, capsules, and injections for the oncology segment
The facility will manufacture tablets, capsules, and injections for the oncology segment
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
10+ emerging markets, Japan & ANZ transition in final phase
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
